共 50 条
- [41] Systematic Literature Review of Real-World Effectiveness Results Data for First-Line Ibrutinib in Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma Drugs - Real World Outcomes, 2023, 10 : 11 - 22
- [49] Real-World Treatment Switching and Sequencing to Next Line of Therapy of Zanubrutinib, Acalabrutinib, and Ibrutinib in Chronic/Small Lymphocytic Leukemia (CLL/SLL) CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S358 - S359